MTOR and tuberous sclerosis: Everolimus, an mTOR inhibitor, is approved in many countries for the treatment of renal angiomyolipoma, lymphangioleiomyomatosis (LAM) and/or partial-onset epilepsy associated with TSC in addition to SEGA [3, 11].